David B. Roberts - 27 Mar 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: President and Director, Director
Signature: /s/ Nathan Ulrich
Issuer symbol: LMAT
Transactions as of: 27 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 31 Mar 2025, 17:14:07 UTC
Previous filing: 11 Mar 2025
Next filing: 02 Jun 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+1	+5.6%	$0.000000	16	27 Mar 2025	Common Stock	1		Direct	F1
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+2	+7.6%	$0.000000	22	27 Mar 2025	Common Stock	2		Direct	F2
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+3	+13%	$0.000000	29	27 Mar 2025	Common Stock	3		Direct	F3
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+3	+13%	$0.000000	28	27 Mar 2025	Common Stock	3		Direct	F4
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+4	+30%	$0.000000	18	27 Mar 2025	Common Stock	4		Direct	F5
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+5	+38%	$0.000000	18	27 Mar 2025	Common Stock	5		Direct	F6
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+3		$0.000000	3	27 Mar 2025	Common Stock	3		Direct	F7
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+0		$0.000000	0	27 Mar 2025	Common Stock	0		Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4	These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6	These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8	These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.